Phase
Alumni community member
ImmuneBiotech
ImmuneBiotech AB is an innovative microbiome research company, discovering and developing novel therapeutics based on probiotics, immunobiotics and synbiotic formulations targeting the microbiome. The company has a pre-clinical stage pipeline of therapeutic lactobacilli combinations for the treatments of chronic inflammatory and infectious diseases.
Non-invasive cardiac pressure monitoring device
Accelerated drug development in oncology
3D cell culture systems
Rapid Diagnostics for Multi-pathogen detection
Individualised information of the intestinal flora
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Pest control solutions for bed bugs
Neonatal Lung Analyzer
Prebiotics for irritable bowel syndrome
Nanotechnology based infection control
Models for autoimmune & inflammatory conditions
Excellence in designing & executing drug discovery
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Male-Factor Infertility Diagnostics
Customized in vitro and in vivo services
Stroke detection device
Wound treatment gel
Regenerative medicine & cancer
